Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol
Biospace,
SAN DIEGO--( BUSINESS WIRE )-- Ligand Pharmaceuticals Inc. (NASDAQ: LGND) presented positive results today from a Phase 1…
SAN DIEGO--( BUSINESS WIRE )-- Ligand Pharmaceuticals Inc. (NASDAQ: LGND) presented positive results today from a Phase 1…
Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO --(BUSINESS WIRE)-- Ligand Pharmaceuticals…
SAN DIEGO--()-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive resultstoday from a Phase 1 clinical…
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive results today from a Phase 1 clinical trial of its…